SavedAdd your journal

Journals / Erciyes Tıp Dergisi / 2002 / Cilt: 24 - Sayı: 3

Subclavian vein obstruction: A rare complication in malignant mesothelioma

Subklavyan ven tıkanıklığı: Malign mezotelyomada nadir bir komplikasyon

Nevzat ÖZCAN
H. Şenol COŞKUN
Bülent ESER
Ali ÜNAL
Mustafa ÇETİN
Mustafa ALTINBAŞ
Özlem ER
Pages
144–148
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients with unilateral obstruction signs must be evaluated for any obstruction proximal to superior vena cava.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The most common vascular complication due to thoracic malignancies is superior vena cava syndrome.
📊
Key Findings & Data:We present a 48-years-old female patient with malignant mesothelioma and subclavian vein obstruction.
💡
Conclusion & Impact:Patients with unilateral obstruction signs must be evaluated for any obstruction proximal to superior vena cava.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The most common vascular complication due to thoracic malignancies is superior vena cava syndrome. Other vascular complications are very rare. We present a 48-years-old female patient with malignant mesothelioma and subclavian vein obstruction. Patients with unilateral obstruction signs must be evaluated for any obstruction proximal to superior vena cava.

Özet

Toraks içerisinde yerleşen malign hastalıklarda karşılaşılan en sık vasküler komplikasyon, vena kava superiyor sendromudur. Diğer vasküler yapıların tutulması oldukça azdır. Burada sağ subklavyen ven tıkanıklığı saptanan malign mezotelyomalı 48 yaşındaki kadın hasta sunuldu. Tek taraflı tıkanıklık bulguları olan hastalar, vena kava superiyor düzeyinin üstündeki tıkanıklıklar için değerlendirilmelidir.

🔖

Cite This Article

ÖZCAN, N., COŞKUN, H. Ş., ESER, B., ÜNAL, A., ÇETİN, M., ALTINBAŞ, M., ER, Ö. (2022). Subclavian vein obstruction: A rare complication in malignant mesothelioma. Erciyes Tıp Dergisi, Cilt: 24 - Sayı: 3, 144–148. https://ajindex.com/articles/502898

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Yahalom J. Superior Vena Cava Syndrome. In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer Principles and Practice of Oncology. 5th ed. Lippincoltt-Raven, Philadelphia 1997, pp 2469-2486
  2. Scalier JP, Feld R. Superior vena cava obstruction syndrome: recommendations for management. Cancer Treat Rev 1985; 12: 209-218
  3. Mason BA. Axillary-subclavian Vein Occlusion in patients with lung neoplasms. Cancer 1981; 48: 1886-1889
  4. Haskell CM, Sadeghi A. Superior vena cava syndrome. In: Haskell CM (ed). Cancer treatment. 4th ed. W.B. Saunderders Company, Philadelphia 1995, pp 1159-1162
  5. Tayade BO, Salvi SS, Agarwal IR. Study of superior vena cava syndrome—aetiopathology, diagnosisand management. J Assoc Physicians India 1994;_____42:609-U
  6. Antman KH, Schiff PB, Pass HI. Benign and malignant mesothelioma. In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer Principles and Practice of Oncology. 5th ed. Lippincoltt-Raven, Philadelphia 1997, pp 1853-1878
  7. Mustafa Çetin, Bülent Eser, Ali Ünal, ve ark. ST segment yükselmesi ile seyreden dijfüz malign plevral mezotelyomanın perikard invazyonu. Erciyes Tıp Dergisi 1999 21: 229-234
  8. Ragalie GF, Varkey B, Choi H. Malignant pleural mesothelioma presenting as superior vena cava syndrome. Can Med Assoc J 1983, 128: 689-691
  9. Martin AA, Sitton JE, Daroca PJ Jr, Moulder PV, Shepard DL. Superior vena cava syndrome associated with malignant mesothelioma. J La State MedSoc 1991; 143:33-35
  10. Rusch VW, Figlin RA. Pleural mesothelioma. In: Haskell CM (ed). Cancer treatment. 4th ed. W.B. Saunderders Company, Philadelphia 1995, pp 421-425
  11. İçli F, Karaoguz H, Hastürk S, et al. Two dose levels of' ifosfamide in malignant mesothelioma. Lung Cancer 1996; 15:207-213
  12. Martinez-Albaladejo M, Garcia-Lopez B, Alguacil-Garcia G, Paco-Moya M. Thrombosis of the axilllary vein as initial manifestation of epidermoid carcinoma of the lung. An Med Interna 1994; 11: 618-619
  13. Stewart IE. Superior vena cava syndrome: an oncologic complication. Semin Oncol Nurs 1996; 12: 312-317
  14. Tanigawa N, Sawada S, Mishima K, et al. Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors. Comparisons with conventional treatment. Ada Radiol 1998; 39: 669-674.